Hangzhou Biotest Biotech Co.,Ltd. (688767.SS)
CNY 38.25
(-0.52%)
CNY 38.25
(-0.52%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 442.11 Million CNY | -76.73% |
| 2022 | 1.9 Billion CNY | 4.57% |
| 2021 | 1.81 Billion CNY | 110.09% |
| 2020 | 865.37 Million CNY | 314.37% |
| 2019 | 208.84 Million CNY | 15.83% |
| 2018 | 180.3 Million CNY | 48.07% |
| 2017 | 121.77 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 128.07 Million CNY | -5.57% |
| 2024 Q3 | 120.18 Million CNY | -5.04% |
| 2024 Q1 | 135.62 Million CNY | 4.43% |
| 2023 Q2 | 108.39 Million CNY | 4.54% |
| 2023 FY | 442.36 Million CNY | -76.73% |
| 2023 Q4 | 129.87 Million CNY | 29.66% |
| 2023 Q3 | 100.16 Million CNY | -7.59% |
| 2023 Q1 | 103.68 Million CNY | -28.23% |
| 2022 Q3 | 232.74 Million CNY | -54.06% |
| 2022 Q1 | 1.01 Billion CNY | 223.12% |
| 2022 Q2 | 506.65 Million CNY | -50.19% |
| 2022 FY | 1.9 Billion CNY | 4.57% |
| 2022 Q4 | 144.47 Million CNY | -37.92% |
| 2021 FY | 1.81 Billion CNY | 110.09% |
| 2021 Q4 | 314.82 Million CNY | -8.87% |
| 2021 Q3 | 345.46 Million CNY | -48.13% |
| 2021 Q2 | 665.95 Million CNY | 35.4% |
| 2021 Q1 | 491.83 Million CNY | 121.97% |
| 2020 FY | 865.37 Million CNY | 314.37% |
| 2020 Q4 | 221.57 Million CNY | 47.38% |
| 2020 Q3 | 150.33 Million CNY | -63.76% |
| 2020 Q2 | 414.84 Million CNY | 427.73% |
| 2020 Q1 | 78.6 Million CNY | 0.0% |
| 2019 FY | 208.84 Million CNY | 15.83% |
| 2018 FY | 180.3 Million CNY | 48.07% |
| 2017 FY | 121.77 Million CNY | 0.0% |